Tibet Rhodiola Pharmaceutical Holding Co., Ltd. logo

Tibet Rhodiola Pharmaceutical Holding Co., Ltd. (600211)

Market Open
15 Oct, 06:58 AM
SSE SSE
¥
36. 63
-0.08
-0.2179%
¥
11.3B Market Cap
- P/E Ratio
3.87% Div Yield
2.68M Volume
- Eps
¥ 36.71
Previous Close
Add Transaction
Day Range
36.32 37.09
Year Range
34.8 49.85
Want to track 600211 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Tibet Rhodiola Pharmaceutical Holding Co., Ltd. (600211) Statistics

Valuation metrics

Market Cap 11.3B
Enterprise value 11.56B
Trailing P/E (ttm) 12.06
Forward P/E -
PEG ratio -9.32
Price/Sales (ttm) 4.11
Price/Book (mrq) 2.99
Enterprise Value/Revenue 4
Enterprise Value/EBITDA 11.01

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.52M
Average volume (90 days) 4.24M

Price summary

52-Week low 34.8
52-Week high 49.85
Beta -
50-Day moving average 37.39
200-Day moving average 39.01

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 2.02
Trailing annual dividend yield 0.055%
5-Year annual dividend yield -
Payout ratio 1.21
Dividend Date 15 Sep 2026
Ex-Dividend Date 15 Sep 2026
Last split factor 1:1
Last split Date 30 Apr 2024

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.34%
Operating margin 0.29%

Operational effectiveness

Return on assets 0.15%
Return on equity 0.26%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 9.06
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 3.07
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 11.75
Total debt (mrq) -
Total Debt/Equity (mrq) 0.3
Current ratio (mrq) 2.87%
Book value per share (mrq) 13.27

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -